Novation strikes supply agreements
NHD, Diagnostic Imaging, and Marconi Medical Systems have joined in a national distribution agreement with Novation, the supply company of VHA and the University HealthSystem Consortium (UHC).The three-year agreement, which covers radiology supplies and
NHD, Diagnostic Imaging, and Marconi Medical Systems have joined in a national distribution agreement with Novation, the supply company of VHA and the University HealthSystem Consortium (UHC).
The three-year agreement, which covers radiology supplies and services, takes effect April 1. It may be extended for up to two additional years. Novation is the largest supply cost management company in healthcare, managing more than $15 billion in annual purchases for 2100 VHA and UHC members. Some 5300 other organizations can purchase supplies under Novation's agreements.
The newest agreement includes distribution of conventional analog and dry diagnostic imaging film, barium, and other medical imaging supplies, accessories, and services. NHD is owned by 25 large regional distributors of medical imaging supplies that work collaboratively to negotiate and manage national account contract business. Diagnostic Imaging offers a range of products from consumables to imaging hardware. Marconi, through its Health Care Products division, distributes more than 22,000 medical imaging supplies and accessories.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
